Title : Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.

Pub. Date : 2018 Jul 3

PMID : 29970890






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Sorafenib ADAM metallopeptidase domain 17 Homo sapiens